The digital health solutions provider reported improved H1 results but faces critical funding challenges. With a cash runway extending only to November, the company is urgently exploring fundraising options to sustain operations.
The digital health platform provider reports revenue growth and new partnerships, but faces critical cash constraints. A fundraising effort is planned to extend operations beyond November 2025.
The healthcare company will report its interim results for the period ended 30 June 2025 on September 8th.
The healthcare technology company has announced a change in shareholding, with Dowgate Group Limited reducing its stake in the business.
The healthcare company provides an update on its focus areas and cost management efforts ahead of its AGM.
The healthcare company provides details on its upcoming Annual General Meeting.
The digital health company reported widening losses and a material uncertainty about its ability to continue as a going concern, despite modest revenue growth and new partnerships.
The healthcare company has granted share options to its top executives as part of their compensation packages.
The healthcare company provides a positive business update, extending its cash runway and announcing a new collaboration with a major pharmaceutical partner.
The healthcare company has entered a collaboration with a major pharmaceutical firm to support patients with inflammatory bowel disease, leveraging its digital platform and resilience-based approach.